Navigation Links
Efficient analysis of small quantity of cells improves chances to understand disease
Date:4/14/2014

For more than a decade Chang Lu, associate professor of chemical engineering at Virginia Tech, has worked on the development of tools to efficiently analyze living cells. The long-term goal is to gain a better understanding of a range of diseases.

In his lab, Lu and his students develop small devices with micrometer features for examining molecular events inside cells. These devices promote high sensitivity and are particularly suited for studying a low number of cells.

Based on their record of achievements, the National Institutes of Health (NIH) has awarded Lu a new $1.3 million, four-year research project, commonly referred to as an RO1 grant, to continue his work in probing dynamics in protein-DNA interactions during disease development. His collaborators are Liwu Li, professor of biological sciences at Virginia Tech, and Kai Tan, associate professor of internal medicine of the University of Iowa Carver College of Medicine.

Lu's earlier awards include a prestigious National Science Foundation CAREER Award and a Walter H. Coulter Early Career Award in Biomedical Engineering. He is also a core member of the School of Biomedical Engineering and Sciences, part of the Institute for Critical Technology and Applied Science at Virginia Tech.

Under the support of the new R01 grant, they will use live animal experiments with laboratory mice to understand the changes in the protein-DNA interaction as a disease develops, using tiny amounts of blood samples.

These blood samples are processed through Lu's investigative procedure called chromatin immunoprecipitation (ChIP) to examine the protein binding to DNA sites. The unique aspect of Lu's procedure is it produces reliable results based on as few as 10 to 100 cells as opposed to the previous standard that required as many as millions of cells, giving researchers a much more manageable process to use. The early versions of the work on this procedure were described in the journal, Lab on a Chip.

Lu's group will then monitor the same live mouse over the course of the disease development.

"We believe that the single live animal data will grant unique insights into the molecular events involved in these biological processes and provide an important basis for diagnosis, prognosis, drug design and discovery, and treatment strategy. Such data also most closely mimic what occurs in human patients during disease development and treatment, thus offering direct clinical relevance," Lu explained.

Lu's specific technique (dubbed as microfluidic chromatin immunoprecipitation) is the subject of a patent filed by Virginia Tech Intellectual Properties (VTIP) on his behalf, and the group's research appears in premier microfluidics and biomedical technology journals.

Lu earned his bachelor's degree in chemistry at Peking University in 1998, followed by a master's and a doctoral degree in chemical engineering in 2001 and in 2002, respectively, from the University of Illinois at Urbana-Champaign. He was a post-doctoral research fellow in applied physics at Cornell University from 2002 until 2004.


'/>"/>

Contact: Lynn Nystrom
tansy@vt.edu
540-231-4371
Virginia Tech
Source:Eurekalert  

Related medicine news :

1. Stand-alone facility for organ retrieval is more efficient, less costly than hospital
2. Neuropsychological assessment more efficient than MRI for tracking disease progression
3. Sensor system improves air quality while making building ventilation more energy efficient
4. Automated system could efficiently identify high-risk osteoporosis patients
5. Successful and Busy Veterinary Clinics: Become More Efficient with Updated and Advanced Time Clock Software
6. How to Make 2014 the Year Your Agency Becomes More Efficient, Improves Communication and Goes Mobile with Online Services from Aladtec
7. National Energy Technologies Announces the Addition of a Revolutionary New Efficient Motor
8. Los Angeles Hair Transplant Surgeon Doubles the Number of Grafts in FUE Hair Restorations Producing More Efficient FUE Hair Transplantation
9. More Efficient Way to Grow Heart Muscle from Stem Cells Could Yield New Regenerative Therapies
10. H7N9 influenza virus not adapted to efficient human-to-human transmission
11. Couple Chooses Endless Pool for Their Energy Efficient Home
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Efficient analysis of small quantity of cells improves chances to understand disease
(Date:4/24/2017)... ... April 24, 2017 , ... MAP ... elevated anxiety levels in people with addiction who are served by MAP’s patient ... biosensing wearable device that monitors heart and breath rates to identify anxiety levels ...
(Date:4/24/2017)... ... April 24, 2017 , ... Come to PAINWeekEnd (PWE) ... Jim Walter Blvd, for an educational and exciting 2-day program. , An attendee ... hearing this before they approach patients” about the course entitled Ain't Misbehavin': Decreasing and ...
(Date:4/24/2017)... ... ... “Reflections of God’s Work”: an enlightening collection of life lessons leading each ... published author, Jerri Broglin, a survivor of great loss who gained insight on how ... for those searching for answers, as we are finding the answers that are so ...
(Date:4/24/2017)... Gainesville, Florida (PRWEB) , ... April 24, 2017 , ... ... at the University of Florida. The event will be held at 7:30 pm on ... and Ken Block and Drew Copeland of Sister Hazel, will support the UF Collegiate ...
(Date:4/23/2017)... ... April 23, 2017 , ... "An event Horizon is a place where ... in my Art and Music. These are created as Metaphysical Transformations where music, which ... mystery culminate to the ultimate singularity.", -- Karen Salicath Jamali , Karen will also ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  AbbVie (NYSE: ABBV), a global ... of chronic hepatitis C virus (HCV) infected patients ... and compensated cirrhosis (Child-Pugh A) achieved sustained virologic ... with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). ... following 12 weeks of G/P treatment without ribavirin. ...
(Date:4/20/2017)... DUBLIN , April 20, 2017 ... "Latin America Pharmaceutical Contract Manufacturing Services Market Analysis By Service ... And Segment Forecasts, 2014 - 2025" report to their ... The Latin ... USD 21.0 billion by 2025 Low drug registration ...
(Date:4/19/2017)... 19, 2017  IRIDEX Corporation (Nasdaq: IRIX ... for the first quarter 2017 after the close of ... team will host a corresponding conference call beginning at ... Investors interested in listening to the conference call may ... or (703) 326-3030 for international callers, using conference ID: ...
Breaking Medicine Technology: